473. Sethi A, et al. (2019) J Oral Maxillofac Pathol, 23: 284. 474. Dickinson MJ, et al. (2022) N Engl J Med, 387: 2220. 475. Zahavi D, et al. (2018) Antib Ther, 1: 7. 476. Desai AV, et al. (2022) J Clin Oncol, 40: 4107. 477. Grossman JE, et al. (2021) Oncogene, 40: 1393. 478. Aldrighetti CM, et al. (2021) JAMA Netw Open, 4: e2133205. 479. Nassar AH, et al. (2022) Cancer Cell, 40: 1161. 480. Jenkins RW, et al. (2018) Br J Cancer, 118: 9. 481. Gauci ML, et al. (2019) Clin Cancer Res, 25: 946. 482. Hegde PS, et al. (2020) Immunity, 52: 17. 483. Hodi FS, et al. (2016) J Clin Oncol, 34: 1510. 484. Claret L, et al. (2018) Clin Cancer Res, 24: 3292. 485. Messmer AS, et al. (2021) Wien Klin Wochenschr, 133: 1318. 486. Neelapu SS, et al. (2017) N Engl J Med, 377: 2531. 487. Gust J, et al. (2017) Cancer Discov, 7: 1404. 488. Maude SL, et al. (2014) Cancer J, 20: 119. 489. Sengupta R, et al. (2018) Clin Cancer Res, 24: 4351. 490. Shimabukuro-Vornhagen A, et al. (2018) J Immunother Cancer, 6: 56. 491. Cappell KM, et al. (2023) Nat Rev Clin Oncol, 20: 359. 492. Cappell KM, et al. (2020) J Clin Oncol, 38: 3805. 493. Brudno JN, et al. (2019) Blood Rev, 34: 45. 494. Brudno JN, et al. (2016) Blood, 127: 3321. 495. Locke FL, et al. (2019) Lancet Oncol, 20: 31. 496. Logue JM, et al. (2021) Haematologica, 106: 978. 497. Cordeiro A, et al. (2020) Biol Blood Marrow Transplant, 26: 26. 498. Aggarwal C, et al. (2016) Annals of Oncology, 27. 499. Postow MA, et al. (2018) N Engl J Med, 378: 158. 500. Wang PF, et al. (2017) Front Pharmacol, 8: 730. 501. Choi J, et al. (2020) Immune Netw, 20: e9. 502. Johnson DB, et al. (2022) Nat Rev Clin Oncol, 19: 254. 503. Mor A, et al. (2021) Front Cell Dev Biol, 9: 790386. 504. Cardena-Gutierrez A, et al. (2022) Front Med (Lausanne), 9: 908752. 505. Chaput N, et al. (2017) Ann Oncol, 28: 1368. 506. Manson G, et al. (2016) Ann Oncol, 27: 1199. 507. Martins F, et al. (2019) Nat Rev Clin Oncol, 16: 563. 508. Khalid AB, et al. (2022) J Natl Compr Canc Netw, 20: 1316. 509. Zhang XT, et al. (2022) Cancer Cell Int, 22: 363. 510. Li M, et al. (2023) J Natl Cancer Inst, 115: 295. 511. Muhimpundu S, et al. (2021) Cancers (Basel), 13. 512. Ahn JC, et al. (2022) Hepatology. 513. Alqazaqi R, et al. (2022) JAMA Netw Open, 5: e2228877. 514. Al Hadidi S, et al. (2022) JAMA Netw Open, 5: e228161. 515. Xie N, et al. (2023) Signal Transduct Target Ther, 8: 9. 516. Grimmett E, et al. (2022) Discov Oncol, 13: 31. 517. Saxena M, et al. (2021) Nat Rev Cancer, 21: 360. 518. Rojas LA, et al. (2023) Nature, 618: 144. 519. Mørk SK, et al. (2023) J Clin Oncol, 41: 9551. 520. Huff AL, et al. (2022) J Clin Invest, 132. 521. Lorentzen CL, et al. (2022) Lancet Oncol, 23: e450. 522. Karasarides M, et al. (2022) Cancer Immunol Res, 10: 372. 523. Alilou M, et al. (2022) Sci Adv, 8: eabq4609. 524. Pardoll DM (2012) Nature Reviews Cancer, 12. 525. Acharya N, et al. (2020) J Immunother Cancer, 8. 526. Tagliamento M, et al. (2021) Immunotargets Ther, 10: 185. 527. Chauvin JM, et al. (2020) J Immunother Cancer, 8. 528. Cho BC, et al. (2022) Lancet Oncol, 23: 781. 529. Johnson ML, et al. (2022) J Clin Oncol, 40: 397600. 530. Chiang EY, et al. (2022) J Immunother Cancer, 10. 531. Chao MP, et al. (2012) Curr Opin Immunol, 24: 225. 532. Chao MP, et al. (2019) Front Oncol, 9: 1380. 533. Jiang Z, et al. (2021) J Hematol Oncol, 14: 180. 534. Shafer P, et al. (2022) Front Immunol, 13: 835762. 535. Saez-Ibanez AR, et al. (2022) Nat Rev Drug Discov, 21: 631. 536. Liu S, et al. (2021) J Hematol Oncol, 14: 7. 537. Daher M, et al. (2021) Clin Transl Immunology, 10: e1274. 538. Trujillo JA, et al. (2018) Cancer Immunol Res, 6: 990. 539. Zhao Y, et al. (2022) Cancers (Basel), 14. 540. Rohaan MW, et al. (2022) N Engl J Med, 387: 2113. 541. Bashor CJ, et al. (2022) Nat Rev Drug Discov, 21: 655. 542. Tran E, et al. (2016) N Engl J Med, 375: 2255. 543. Martinov T, et al. (2023) Annu Rev Cancer Biol, 7: 331. References AACR Cancer Progress Report 2023 177
RkJQdWJsaXNoZXIy NTkzMzk=